- Home
- INVA vs MMI Comparison
INVA vs MMI Comparison
Compare INVA & MMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INVA
- MMI
- Stock Information
- Founded
- INVA 1996
- MMI 1971
- Country
- INVA United States
- MMI United States
- Employees
- INVA N/A
- MMI N/A
- Industry
- INVA Biotechnology: Pharmaceutical Preparations
- MMI Real Estate
- Sector
- INVA Health Care
- MMI Finance
- Exchange
- INVA Nasdaq
- MMI Nasdaq
- Market Cap
- INVA 1.3B
- MMI 1.2B
- IPO Year
- INVA 2004
- MMI 2013
- Fundamental
- Price
- INVA $18.72
- MMI $31.75
- Analyst Decision
- INVA Strong Buy
- MMI Sell
- Analyst Count
- INVA 3
- MMI 2
- Target Price
- INVA $40.33
- MMI $30.00
- AVG Volume (30 Days)
- INVA 947.9K
- MMI 120.6K
- Earning Date
- INVA 08-04-2025
- MMI 08-07-2025
- Dividend Yield
- INVA N/A
- MMI 1.57%
- EPS Growth
- INVA N/A
- MMI N/A
- EPS
- INVA N/A
- MMI N/A
- Revenue
- INVA $369,844,000.00
- MMI $711,994,000.00
- Revenue This Year
- INVA $3.75
- MMI $11.69
- Revenue Next Year
- INVA $12.62
- MMI $24.07
- P/E Ratio
- INVA N/A
- MMI N/A
- Revenue Growth
- INVA 18.70
- MMI 14.79
- 52 Week Low
- INVA $16.67
- MMI $27.61
- 52 Week High
- INVA $22.00
- MMI $42.80
- Technical
- Relative Strength Index (RSI)
- INVA 36.02
- MMI 56.44
- Support Level
- INVA $19.35
- MMI $30.76
- Resistance Level
- INVA $20.58
- MMI $31.62
- Average True Range (ATR)
- INVA 0.46
- MMI 0.66
- MACD
- INVA -0.07
- MMI -0.03
- Stochastic Oscillator
- INVA 3.63
- MMI 64.50
About INVA Innoviva Inc.
Innoviva Inc is a company with a portfolio of royalties healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.
About MMI Marcus & Millichap Inc.
Marcus & Millichap Inc is a national brokerage firm specializing in commercial real estate investment sales, financing, research, and advisory services. The company offers three primary services to its clients: commercial real estate investment brokerage, financing, and ancillary services, including other research, advisory, and consulting services. The company generates revenues by collecting fees on the sale and financing of commercial properties. These fees consist of commissions collected upon the sale of a property and fees collected from the placement of loans.